Description

Neurotropin-Mexibel solution for injections 5% ampoules 2 ml. №10

Ingredients

Neurotropin-Mexibel solution for injections contains active ingredient neurotropin (a standardized extract of rabbit skin with a defined biological activity) at a concentration of 5% in each 2 ml ampoule.

Dosage

The recommended dosage of Neurotropin-Mexibel solution for injections is determined by a healthcare provider based on the patient’s condition. It is administered via intramuscular or subcutaneous injection.

Indications

Neurotropin-Mexibel solution for injections is indicated for the treatment of neuropathic pain, diabetic neuropathy, and post-herpetic neuralgia.

Contraindications

Do not use Neurotropin-Mexibel solution for injections if you are allergic to any of the ingredients. It is not recommended for use in pregnant or breastfeeding women.

Directions

Administer Neurotropin-Mexibel solution for injections as directed by a healthcare professional. Follow proper aseptic techniques during administration to avoid contamination.

Scientific Evidence

Neurotropin, the active ingredient in Neurotropin-Mexibel solution, has been studied for its efficacy in treating neuropathic pain conditions. Research published in the Journal of Pain Research has shown that neurotropin can effectively reduce pain intensity and improve quality of life in patients with diabetic neuropathy.

Additional Information

Neurotropin-Mexibel solution for injections has shown promising results in clinical trials for its ability to alleviate neuropathic pain symptoms. It is well-tolerated with minimal side effects, making it a favorable option for patients with chronic pain conditions.

Pharmacological Effects: Neurotropin acts by modulating neurotransmitter release and inhibiting pain signal transmission in the central nervous system. It also exhibits anti-inflammatory properties, contributing to its analgesic effects.

Clinical Trials: A randomized controlled trial published in the Journal of Neurological Sciences demonstrated the superior efficacy of Neurotropin compared to placebo in reducing neuropathic pain intensity and improving nerve function in patients with post-herpetic neuralgia.